Medicine
Icotyde 200 mg tablet
Icotyde 200 mg tablet is a prescription medicine containing Icotrokinra for oral use, marketed by Janssen Biotech, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 °C to 25 °C (68 °F to 77 °F), excursions permitted between 15 °C…
Key facts
- Active ingredient (INN)
- Icotrokinra
- Brand
- Icotyde
- Strength
- 200 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 blister pack, 1 bottle
- Marketing authorisation holder
- Janssen Biotech
- Manufacturer
- Janssen Biotech
- Origin register
- US FDA, United States
- Storage
- Store at 20 °C to 25 °C (68 °F to 77 °F), excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). Store in original package to protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AC28 Icotrokinra
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 March 2026
- Identifiers
- RxCUI 2739036, 2739042DailyMed set ID aee3c963-edc0-4252-8769-cdf6c7cdc21aNDC 57894-201Application NDA220149
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 carton / 7 tablet, film coated in 1 blister pack | 57894-201-07 | Janssen Biotech | 17 March 2026 |
| 1 bottle in 1 carton / 30 tablet, film coated in 1 bottle | 57894-201-30 | Janssen Biotech | 17 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Icotrokinra is a prescription medicine indicated for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Icotrokinra for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IcotrokinraFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ICOTYDE prescribing information (Janssen Biotech) · U.S. National Library of Medicine, DailyMed
- Icotyde: European public assessment report (EPAR) · European Medicines Agency
Need Icotyde 200 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.